Centene To Participate at BMO Capital 2020 Prescriptions For Success Healthcare Conference

On June 16, 2020 Centene Corporation (NYSE: CNC) reported it will participate in the one-day, virtual-only BMO Capital 2020 Prescriptions for Success Healthcare Conference (Press release, Centene , JUN 16, 2020, View Source [SID1234561160]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

Centene will participate in a virtual format on Tuesday, June 23, 2020, at 8:30 a.m. Eastern Daylight Time (EDT). A simultaneous live audio webcast is available at: View Source

A webcast replay will be available afterwards via the Company’s website at www.centene.com under the Investors section.

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!